This online course is adapted from the 1-day CT Screening Symposium featured at the 2024 World Conference on Lung Cancer, September 7, 2024. The course is focused on lung cancer screening technologies and best practices, including topics relevant to an international audience. Faculty will provide current data to highlight successes and address knowledge gaps. As a result of the symposium, the participant will be able to apply current knowledge to advance lung cancer screening relevant to their health care setting. 

Workshop Sessions:

• Topic 1: Implementation for CT Screening Programs - Challenges and Successes
• Topic 2: Integration of Mobile CT Screening
• Topic 3: Equity in CT Screening
• Topic 4: Future Directions & Emerging Technologies

Brought to you by the IASLC Screening and Early Detection Committee

Radiologists, oncologists, pulmonologists, thoracic surgeons, radiologic technologists, researchers in the field of lung cancer, healthcare administrators, healthcare policy makers, and industry representatives involved in CT imaging and lung cancer diagnostics.

Upon completion of this activity, the participants should be able to:

• Evaluate the global challenges in lung cancer screening program implementation with updates on progress in different health settings. 
• Review factors that may influence integration of mobile CT screening and its potential role in a lung cancer screening program. 
• Discuss disparities in access to lung cancer screening and explain strategies for promoting equity in program implementation. 
• Describe emerging technologies in lung cancer screening, enabling attendees to anticipate and adapt to future advancements in the field.

Chairs: 

• Annette Maree McWilliams, MBBS, FRACP, Respiratory Medicine, Fiona Stanley Hospital, Perth, Australia
• Ella Kazerooni, MD, MS, Radiology, University of Michigan, Ann Arbor, MI, USA
• David Chi-Leung Lam, MD, Respiratory Medicine, University of Hong Kong, Hong Kong, China
• Witold Rzyman, MD, Professor, Department of Thoracic Surgery, Medical University of Gdansk, Gdansk, Poland
• Chi-Fu Jeffrey Yang, MD, Thoracic Surgery, Massachusetts General Hospital, Winchester, MA, USA

Presenters: 

• Kazuto Ashizawa, MD, Professor, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
• Haval Balata, MD, PhD, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK
• Sue Crengle, MBChB, PhD, Ngai Tahu Maori Health Research Unit, University of Otago, Dunedin, New Zealand
• John Field, PhD, FRCPath, Molecular and Clinical Cancer Center, The University of Liverpool, Liverpool, UK
• Florian Fintelmann, MD, Radiology, Massachusetts General Hospital, Boston, MA, USA
• Efrén Flores, MD, Radiology, Massachusetts General Hospital, Boston, MA, USA
• Catherine Jones,, MD, Professor, I-MED Radiology, University of Sydney, Australia
• Ella Kazerooni, MD, MS, Radiology, University of Michigan, Ann Arbor, MI, USA
• Shannon Kozlovich, PhD, National LGBTQI+ Cancer Network, Providence, RI
• David Chi-Leung Lam, MD, Respiratory Medicine, The University of Hong Kong, Hong Kong, China
• Stephen Lam, MD, FRCPC, Integrative Oncology, BC Cancer & the University of British Columbia, Vancouver, BC, Canada
• Pyng Lee, MD, PhD, Respiratory and Critical Care Medicine, National Univeristy of Singapore, Singapore
• Peter Mazzone, MD, Cleveland Clinic Foundation, Cleveland, OH, USA
• Ray Osarogiagbon, MBBS, Baptist Cancer Center, Germantown, TN, USA
• Mary Reid, MD, Roswell Part Comprehensive Cancer Center, Buffalo, NY, USA
• Witold Rzyman, MD, Professor, Department of Thoracic Surgery, Medical University of Gdansk, Gdansk, Poland
• Ricardo Sales Santos, MD, Hospital Israelita Albert Einstein, Salvador Bahia, Brazil
• Martin Tammemagi, PhD, Professor, Health Sciences Brock University, St. Catharines, Ontario, Canada
• Mellisa Wheeler, BSW, MHA, Atrium Health Levine Cancer, Charlotte, NC, USA
• Helena Wilcox, MSc, BSc, The Health Policy Partnership, London, UK
• Douglas Wood, MD, Professor, University of Washington, Seattle, WA, USA
• David Yankelevitz, MD, Professor, Mount Sinai School of Medicine, New York, NY, USA

The information presented is that of the contributing faculty and does not necessarily represent the views of the International Association for the Study of Lung Cancer and/or any named commercial entity providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated by the faculty presenters. Therefore, before prescribing any medication, please review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse effects.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

If you need any assistance with this activity, please email: education@iaslc.org.